Processing Your Payment

Please do not leave this page until complete. This can take a few moments.

October 5, 2021

Jackson Laboratory names Cardon as president, CEO

Photo | Contributed Lon Cardon.
By Sean Teehan

Jackson Laboratory (JAX), a Maine-based nonprofit biomedical research institution with a location in Farmington, appointed human genetics and drug discovery scientist Lon Cardon as its new president and CEO.

Cardon is a 14-year veteran of the biotech industry, working as a senior vice president at GlaxoSmithKline before joining California biotech company BioMarin Pharmaceutical in 2017, most recently serving as chief scientific strategy officer.

At JAX, Cardon will develop strategy to leverage the organization's expertise in human and animal genetics, and cutting-edge technology like artificial intelligence and machine learning, according to the laboratory.

“The Jackson Laboratory has a unique combination of critical components to finally approach the long-awaited potential of genetics," Cardon said.

Cardon will succeed outgoing CEO Edison Liu, who has helmed the organization for a decade, according to JAX. He is scheduled to start in his new position on Nov. 29.

Sign up for Enews

Most Recent

Most Recent

Related Content

One of Jackson Laboratory’s first Farmington spinoffs aims to create predictive tests for severe newborn illnesses
Thumbnail New Jackson Lab CEO Cardon eyes expansion of Farmington campus, more spinoffs
Thumbnail Jackson Lab nets $140M in research funding in 2021
Eric Wang joins Jackson Laboratory in role to overcome treatment resistance in leukemia

0 Comments

Order a PDF